Vaxcyte, Inc. — Director's Dealing 2025

Sep 10, 2025

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Vaxcyte, Inc. (PCVX)
CIK: 0001649094
Period of Report: 2025-09-08

Reporting Person: Dhaliwal Harpreet S. (Chief Technical Ops Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2025-09-08	Common Stock	F	1204	$32.41	Disposed	33670	Direct

Footnotes

F1: Represents shares surrendered to the Issuer to cover applicable tax withholding obligations realized upon the vesting of RSUs.